Posted Dec 6, 2019, 11:20 am
Fifteen years ago, the federal government said “no” to piracetam.
This was a proposed new ingredient that a company had hoped to market
as a dietary supplement. In 2004, the U.S. Food and Drug Administration
rejected the company’s application, citing “concerns about the evidence” that supposedly showed piracetam was safe.
The agency hasn’t changed its position. But piracetam is widely
available—and hugely popular—as a supplement promoted as boosting
cognitive ability. Unintimidated by FDA warning letters, sellers are advertising this forbidden ingredient in online bazaars.
published this week by JAMA Internal Medicine identified four
supplements sold in the U.S. that contain piracetam, and said so on
their labels. Two of the products were labeled simply
piracetam, while the other two were sold under the names Compel and
NeuroPill. Their manufacturers—BPS, Cognitive Nutrition, Nootropics and
Relentless Improvement—could not be reached for comment. A fifth
company, Specialty Pharmacy, advertised a piracetam product, but the
study didn’t find detectable amounts.
Piracetam, which the study’s lead author, Pieter Cohen, called “the
godfather of all nootropics”—a term for supplements that are supposed to
improve brain power—is prescribed in European
countries for various disorders, including dementia and cognitive
impairment. But a review of medical research found that there’s little
evidence it works, according to the study.
Taking piracetam at pharmaceutical doses can have adverse side
effects, the study said, including anxiety, agitation, depression and
weight gain. The products sampled in the supplement study recommended
dosages that varied wildly, ranging from 831 milligrams to 11,283
milligrams per day.
“Fifteen years ago, the FDA makes it clear this is not a supplement,
and for the last 15 years it’s been sold as a supplement,” said Cohen, a
physician with the Cambridge Health Alliance and Harvard Medical
School. “So we have some serious problems—both with compliance with the
law and enforcement of the law.”
Brain enhancement drugs with a variety of ingredients have been booming
in recent years. From 2006 to 2015, U.S. sales increased from $353
million to $643 million, according to a recent Government Accountability
TucsonSentinel.com relies on contributions from our readers to support our reporting on Tucson’s civic affairs. Donate to TucsonSentinel.com today!
If you’re already supporting us, please encourage your friends, neighbors, colleagues and customers to help support quality local independent journalism.
The FDA has repeatedly targeted companies that sell dietary supplements geared toward cognitive enhancement. In February, the agency posted
12 warning letters and five online advisory letters to companies it
said were illegally selling products that claimed to cure various
illnesses, including Alzheimer’s disease. Scott Gottlieb, the FDA’s
commissioner at the time, stated that the letters were part of a broader
effort to crack down on the dietary supplement industry.
“Simply put, health fraud scams prey on vulnerable populations, waste money and often delay proper medical care,” Gottlieb said.
But deeper in the press statement, he said that while some companies
have stopped selling products after receiving letters, unapproved
products continue to be sold to consumers through new websites. The FDA
has the power to recall supplements, Cohen said, but when one company
stop selling a product another will take its place in the market.
In an email to FairWarning, an FDA official said the agency does not
comment on specific studies. Supplement makers are not permitted to make
claims about treating diseases, the official said, but the agency has
“limited resources to monitor the marketplace for potentially harmful,
or otherwise unlawful, dietary supplements.”
As the JAMA study highlights, distributors aren’t secretive about
advertising piracetam. At least one online distributor even used
piracetam’s long pharmaceutical history as a selling point, claiming that it “has been studied longer and far more in-depth than most dietary supplements.”
As reported by FairWarning, cognitive enhancement supplements are especially popular with middle-aged and older people
who are worried about declining sharpness. But Cohen and other
researchers said that they have strong appeal with younger professionals
who want to maximize productivity.
Lon Schneider, director of the Alzheimer’s Disease Center at the
University of Southern California, said many consumers believe they can
use various combinations of supplements to improve their mental
abilities. Schneider said he’s found some of these supplements in Los
Angeles stores and they are cheap.
“It’s unregulated and potentially dangerous, and almost always not subject to any empirical, systematic testing,” he said.
The Consumer Healthcare Products Association, a supplements industry trade group, called the JAMA study’s findings “concerning.”
“CHPA and our member companies strongly support FDA’s efforts to
remove these potentially dangerous products from the market,” the group
said in a statement.
Support TucsonSentinel.com & let thousands of daily readers know
your business cares about creating a HEALTHIER, MORE INFORMED Tucson
David Seres, director of medical nutrition at Columbia University
Irving Medical Center, said that there are reputable dietary supplement
companies who follow the rules and “put what they say in the bottle.”
But, he said, powerful deregulation took away much of the FDA’s ability to control the industry.
In 1993, while the FDA was considering stronger rules for dietary
supplements, Mel Gibson appeared in a commercial in which federal agents
broke into his home and arrested him for possessing a bottle of Vitamin C.
A public letter-writing campaign resulted in more letters sent to
Congress about the FDA’s rulemaking than all letters sent during the
Vietnam War, Seres said.
The following year, Congress passed the 1994 Dietary Supplement
Health and Education Act, which significantly diminished the FDA’s
“For my money, if I were to be designing the whole thing, I would
require that dietary supplements—which are substances taken for health
benefits—actually have proven health benefits,” Seres said.
Cohen said that the FDA should create a registry of approved dietary
supplements and labels, which would allow consumers to cross-check
products with the government.
There are signs the public is warming to the idea of stronger
regulations for supplements. In October, the Pew Charitable Trusts
published a survey
showing that one in eight adults said that they or a family member
experienced serious side effects from using supplements. The vast
majority of the respondents strongly supported the creation of a
mandatory supplement product listing with the FDA.
“We’re moving to a situation where everyone agrees that the FDA needs more data,” Cohen said. “The question is, how is that going to work? Will the law be written by industry to create more administrative paperwork for the FDA to do?”
FairWarning is a nonprofit news organization based in Southern California that focuses on public health, consumer and environmental issues.